Accelerate Diagnostics (AXDX) Prices 17.5M Share Offering at $2/sh

Go back to Accelerate Diagnostics (AXDX) Prices 17.5M Share Offering at $2/sh

Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock

August 18, 2022 9:30 PM UTC

TUCSON, Ariz., Aug. 18, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate Diagnostics") today announced the pricing of an underwritten public offering of 17,500,000 shares of its common stock at a price to the public of $2.00 per share. The gross proceeds to Accelerate Diagnostics from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be $35.0 million. In addition, Accelerate Diagnostics has granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of its... More